Assessment of myocardial viability with myocardial contrast echocardiography

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The application of noninvasive imaging techniques to assess myocardial viability has become an important part of routine management of patients with acute myocardial infarction and chronic coronary artery disease. Information regarding the presence and extent of viability may help identify patients likely to benefit from revascularization or therapy directed at attenuating left ventricular remodeling. Myocardial contrast echocardiography (MCE) is capable of defining the presence and extent of viability by providing an accurate assessment of microvascular integrity needed to maintain myocellular viability. It is especially suited for the spatial assessment of perfusion, even when myocardial blood flow is reduced substantially in the presence of severe epicardial stenoses or in a bed dependent on collateral perfusion. The routine use of MCE to evaluate viability in patients with acute and chronic coronary artery disease is now feasible with the advent of new imaging technologies and microbubble agents capable of myocardial opacification from venous injections. The utility of this technique for determining treatment strategies has not been established but is forthcoming.

Original languageEnglish (US)
Pages (from-to)417-425
Number of pages9
JournalEchocardiography
Volume19
Issue number5
StatePublished - Jul 2002
Externally publishedYes

Fingerprint

Echocardiography
Coronary Artery Disease
Perfusion
Microbubbles
Ventricular Remodeling
Pathologic Constriction
Myocardial Infarction
Technology
Injections
Therapeutics

Keywords

  • Congestive heart failure
  • Coronary artery disease
  • Myocardial contrast echocardiography
  • Myocardial viability

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Assessment of myocardial viability with myocardial contrast echocardiography. / Lindner, Jonathan.

In: Echocardiography, Vol. 19, No. 5, 07.2002, p. 417-425.

Research output: Contribution to journalArticle

@article{fc507102feca45b7973d8e3c49ff0676,
title = "Assessment of myocardial viability with myocardial contrast echocardiography",
abstract = "The application of noninvasive imaging techniques to assess myocardial viability has become an important part of routine management of patients with acute myocardial infarction and chronic coronary artery disease. Information regarding the presence and extent of viability may help identify patients likely to benefit from revascularization or therapy directed at attenuating left ventricular remodeling. Myocardial contrast echocardiography (MCE) is capable of defining the presence and extent of viability by providing an accurate assessment of microvascular integrity needed to maintain myocellular viability. It is especially suited for the spatial assessment of perfusion, even when myocardial blood flow is reduced substantially in the presence of severe epicardial stenoses or in a bed dependent on collateral perfusion. The routine use of MCE to evaluate viability in patients with acute and chronic coronary artery disease is now feasible with the advent of new imaging technologies and microbubble agents capable of myocardial opacification from venous injections. The utility of this technique for determining treatment strategies has not been established but is forthcoming.",
keywords = "Congestive heart failure, Coronary artery disease, Myocardial contrast echocardiography, Myocardial viability",
author = "Jonathan Lindner",
year = "2002",
month = "7",
language = "English (US)",
volume = "19",
pages = "417--425",
journal = "Echocardiography",
issn = "0742-2822",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Assessment of myocardial viability with myocardial contrast echocardiography

AU - Lindner, Jonathan

PY - 2002/7

Y1 - 2002/7

N2 - The application of noninvasive imaging techniques to assess myocardial viability has become an important part of routine management of patients with acute myocardial infarction and chronic coronary artery disease. Information regarding the presence and extent of viability may help identify patients likely to benefit from revascularization or therapy directed at attenuating left ventricular remodeling. Myocardial contrast echocardiography (MCE) is capable of defining the presence and extent of viability by providing an accurate assessment of microvascular integrity needed to maintain myocellular viability. It is especially suited for the spatial assessment of perfusion, even when myocardial blood flow is reduced substantially in the presence of severe epicardial stenoses or in a bed dependent on collateral perfusion. The routine use of MCE to evaluate viability in patients with acute and chronic coronary artery disease is now feasible with the advent of new imaging technologies and microbubble agents capable of myocardial opacification from venous injections. The utility of this technique for determining treatment strategies has not been established but is forthcoming.

AB - The application of noninvasive imaging techniques to assess myocardial viability has become an important part of routine management of patients with acute myocardial infarction and chronic coronary artery disease. Information regarding the presence and extent of viability may help identify patients likely to benefit from revascularization or therapy directed at attenuating left ventricular remodeling. Myocardial contrast echocardiography (MCE) is capable of defining the presence and extent of viability by providing an accurate assessment of microvascular integrity needed to maintain myocellular viability. It is especially suited for the spatial assessment of perfusion, even when myocardial blood flow is reduced substantially in the presence of severe epicardial stenoses or in a bed dependent on collateral perfusion. The routine use of MCE to evaluate viability in patients with acute and chronic coronary artery disease is now feasible with the advent of new imaging technologies and microbubble agents capable of myocardial opacification from venous injections. The utility of this technique for determining treatment strategies has not been established but is forthcoming.

KW - Congestive heart failure

KW - Coronary artery disease

KW - Myocardial contrast echocardiography

KW - Myocardial viability

UR - http://www.scopus.com/inward/record.url?scp=0036633195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036633195&partnerID=8YFLogxK

M3 - Article

C2 - 12174206

AN - SCOPUS:0036633195

VL - 19

SP - 417

EP - 425

JO - Echocardiography

JF - Echocardiography

SN - 0742-2822

IS - 5

ER -